Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03283202
Title Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Age Groups: adult | senior
Covered Countries USA | ESP | CAN | BEL

Facility Status City State Zip Country Details
George Washington University Washington District of Columbia 20037 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Washington University Saint Louis Missouri 63110 United States Details
UZ Gent Gent 9000 Belgium Details
University Hospital Gasthuisberg Lueven B-3000 Belgium Details
Tom Baker Cancer Center Calgary Alberta T2N 4N2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Hospital Germans Trias I Pujol Badalona 8916 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 8035 Spain Details
Hospital de San Pedro de Alcantara Caceres 10003 Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Clinico Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Virgen Del Rocio Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from for the field